Suppressive function of bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-187 in prostate cancer
Open Access
- 17 October 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Biology & Therapy
- Vol. 23 (1), 1-14
- https://doi.org/10.1080/15384047.2022.2123675
Abstract
Application of bone marrow-derived mesenchymal stem cell-derived exosomes (BMSC-exos) in cancer treatment has been widely studied. Here, we elaborated the function of BMSC-exos containing microRNA-187 (miR-187) in prostate cancer. Differentially expressed miRs and genes were screened with microarray analysis. The relationship between CD276 and miR-187 in prostate cancer was evaluated. Following miR-187 mimic/inhibitor or CD276 overexpression transfection, their actions in prostate cancer cell biological processes were analyzed. Prostate cancer cells were then exposed to BMSC-exos that were treated with either miR-187 mimic/inhibitor or CD276 overexpression for pinpointing the in vitro and in vivo effects of exosomal miR-187. miR-187 was poorly expressed while CD276 was significantly upregulated in prostate cancer. Additionally, restoring miR-187 inhibited the prostate cancer cell malignant properties by targeting CD276. Upregulation of miR-187 led to declines in CD276 expression and the JAK3-STAT3-Slug signaling pathway. Next, BMSC-exos carrying miR-187 contributed to repressed cell malignant features as well as limited tumorigenicity and tumor metastasis. Collectively, this study demonstrated that BMSC-derived exosomal miR-187 restrained prostate cancer by reducing CD276/JAK3-STAT3-Slug axis.Keywords
Funding Information
- General Project of Chongqing Natural Science Foundation
- National Natural Science Foundation of China (No. 81972411)
This publication has 51 references indexed in Scilit:
- MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3Biochemical and Biophysical Research Communications, 2013
- Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumorsStem Cell Research & Therapy, 2013
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progressionJCI Insight, 2013
- Exosomal miRNAs as Biomarkers for Prostate CancerFrontiers in Genetics, 2013
- Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selectionBone, 2012
- Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivoCancer Letters, 2012
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell ProgressionJournal of Urology, 2011
- Therapeutic Potential of Adult Bone Marrow–Derived Mesenchymal Stem Cells in Prostate Cancer Bone MetastasisClinical Cancer Research, 2009
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences of the United States of America, 2007